POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No15/2014
Date of issue:2014-02-06
Short name of the issuer
SOPHARMA AD
Subject
Current report 15 buy back 06022014
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD (the “Company") hereby informs that from 30 January 2014 up to and including 5 February 2014 the Company bought 6 886 own shares representing 0.005% of the share capital of the Company, to the total value of 27 221.75 BGN on the Bulgarian Stock Exchange, the average price per share was 3.95 BGN and sold 511 589 own shares representing 0.39% of the share capital of the Company, to the total value of 2 174 003.21 BGN on the Bulgarian Stock Exchange, the average price per share was 4.25 BGN. The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 017 883, representing 3.80% of the share capital of the Company.
Annexes
FileDescription
Current report 15 buy back 06022014.docCurrent report 15 buy back 06022014
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2014-02-06Ognian DonevExecutive director